Screening for Conditions by Electronic Nose Technology (SCENT III) (Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a cooperative agreement opportunity titled "Screening for Conditions by Electronic Nose Technology (SCENT III)," aimed at developing innovative electronic nose technologies for disease diagnosis and monitoring. This initiative seeks to enhance noninvasive diagnostic platforms that utilize volatile organic compound (VOC) signatures from human skin, thereby improving the detection and analysis of various diseases in everyday settings. The project aligns with the NIH's goal of accelerating the translation of scientific knowledge into effective treatments, with an estimated award date of April 5, 2027, and a project start date on the same day. Interested applicants can reach out to Leah Croucher, PhD, at leah.croucher@nih.gov or by phone at 240-701-2580 for further information.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.